Insights from 2025 ASCO® GI Annual Meeting


 

ASCO® GI 2025 Insights: Preoperative Botensilimab +/- Balstilimab in Resectable Locally Advanced pMMR/dMMR CRC - UNICORN Trial Results

97 views
February 7, 2025
Comments 0
Login to view comments. Click here to Login